Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trialRudolf Benz, Georg Stüssi, Michaël Baumann et al.|Blood Advances|2020Cited by 31
Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)Rudolf Benz, Georg Stüssi, Kornelius Arn et al.|Blood|2018Cited by 0